Ikarian Capital’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-690,050
| Closed | -$179K | – | 120 |
|
|
2025
Q1 | $179K | Hold |
690,050
| – | – | 0.02% | 99 |
|
|
2024
Q4 | $388K | Sell |
690,050
-39
| -0% | -$22 | 0.05% | 91 |
|
|
2024
Q3 | $414K | Hold |
690,089
| – | – | 0.06% | 75 |
|
|
2024
Q2 | $1.86M | Buy |
690,089
+542,000
| +366% | +$1.46M | 0.32% | 37 |
|
|
2024
Q1 | $760K | Sell |
148,089
-1,023,850
| -87% | -$5.25M | 0.08% | 63 |
|
|
2023
Q4 | $629K | Hold |
1,171,939
| – | – | 0.06% | 60 |
|
|
2023
Q3 | $777K | Buy |
1,171,939
+22,449
| +2% | +$14.9K | 0.09% | 50 |
|
|
2023
Q2 | $1.75M | Buy |
+1,149,490
| New | +$1.75M | 0.28% | 35 |
|